Unbound MEDLINE

Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma. Archives of ophthalmology [Arch Ophthalmol] Journal article

 
TitleReduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma.
Author(s)Robin AL, Suan EP, Sjaarda RN, Callanan DG, Defaller J, Alcon Anecortave Acetate for IOP Research Team 
InstitutionBloomberg School of Public Health and Wilmer Institute, Johns Hopkins University, Baltimore, Maryland, USA. arobin@glaucomaexpert.com
SourceArch Ophthalmol 2009 Feb; 127(2):173-8.
MeSHAdult
Aged
Aged, 80 and over
Antihypertensive Agents
Delayed-Action Preparations
Female
Glucocorticoids
Humans
Injections
Intraocular Pressure
Male
Middle Aged
Ocular Hypertension
Pregnadienediols
Prospective Studies
Retinal Diseases
Tonometry, Ocular
Triamcinolone Acetonide
Vitreous Body
AbstractOBJECTIVE: To evaluate the intraocular pressure (IOP)-lowering potential of anecortave acetate (AA) in eyes with steroid-related ocular hypertension inadequately controlled with the maximal tolerated or appropriate medical therapy.
DESIGN: Uncontrolled case series.
METHODS: A total of 8 eyes of 7 subjects with medically uncontrolled IOP following intravitreal or sub-Tenon injections of triamcinolone acetonide were included. All received an 0.8-mL anterior juxtascleral depot of 3% AA solution (24 mg) under topical anesthesia. The IOP was assessed weekly for the first month, then monthly for a minimum of 1 year.
RESULTS: The mean baseline IOP was 39.9 mm Hg. After 1 week, the mean IOP decreased 12 mm Hg (29%; P = .005) and by 1 month, the mean IOP had decreased 14.1 mm Hg (34.5%; P = .003) from baseline. Four eyes required surgical intervention despite a decrease in IOP because of markedly elevated initial IOP and the degree of preexisting glaucomatous optic neuropathy. We observed no adverse events.
CONCLUSIONS: An anterior juxtascleral depot of AA lowers IOP substantially in some eyes with medically uncontrolled steroid-related ocular hypertension. Further study is warranted to clarify the role of AA in treating this condition as well as other forms of glaucoma.
Languageeng
Pub Type(s)Journal Article
PubMed ID19204235
  
Advertise on this site.